430 related articles for article (PubMed ID: 2390105)
1. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
[TBL] [Abstract][Full Text] [Related]
3. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.
Makowska JM; Bonner FW; Gibson GG
Arch Toxicol; 1991; 65(2):106-13. PubMed ID: 1905530
[TBL] [Abstract][Full Text] [Related]
4. Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation.
Makowska JM; Gibson GG; Bonner FW
J Biochem Toxicol; 1992; 7(3):183-91. PubMed ID: 1282571
[TBL] [Abstract][Full Text] [Related]
5. Role of thyroid state on induction by ciprofibrate of laurate hydroxylase and peroxisomal enzymes in rat liver microsomes.
Pacot C; Charmoillaux M; Goudonnet H; Truchot RC; Latruffe N
Biochem Pharmacol; 1993 Apr; 45(7):1437-46. PubMed ID: 8471068
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
[TBL] [Abstract][Full Text] [Related]
7. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ
Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818
[TBL] [Abstract][Full Text] [Related]
8. Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study.
Klinger W; Lupp A; Karge E; Oelschläger H; Rothley D; Danz M; Linss W; Löbel S; Deufel T; Müller M; Klinger M; Kühnel W
Exp Toxicol Pathol; 1998 Sep; 50(4-6):301-14. PubMed ID: 9784002
[TBL] [Abstract][Full Text] [Related]
9. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.
Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR
Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380
[TBL] [Abstract][Full Text] [Related]
11. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the hepatic response to a potent peroxisome proliferator.
Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
[No Abstract] [Full Text] [Related]
13. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
14. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
Orton TC; Parker GL
Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
[TBL] [Abstract][Full Text] [Related]
15. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant enzymes in ciprofibrate-induced oxidative stress.
Dhaunsi GS; Singh I; Orak JK; Singh AK
Carcinogenesis; 1994 Sep; 15(9):1923-30. PubMed ID: 7923586
[TBL] [Abstract][Full Text] [Related]
17. The herbicide dicamba (2-methoxy-3,6-dichlorobenzoic acid) is a peroxisome proliferator in rats.
Espandiari P; Thomas VA; Glauert HP; O'Brien M; Noonan D; Robertson LW
Fundam Appl Toxicol; 1995 Jun; 26(1):85-90. PubMed ID: 7657066
[TBL] [Abstract][Full Text] [Related]
18. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
Rao MS; Dwivedi RS; Subbarao V; Reddy JK
Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate.
Milton MN; Elcombe CR; Gibson GG
Biochem Pharmacol; 1990 Dec; 40(12):2727-32. PubMed ID: 2260995
[TBL] [Abstract][Full Text] [Related]
20. Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years.
Graham MJ; Wilson SA; Winham MA; Spencer AJ; Rees JA; Old SL; Bonner FW
Fundam Appl Toxicol; 1994 Jan; 22(1):58-64. PubMed ID: 8125214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
